- Home
- UUU vs BRTX Comparison
UUU vs BRTX Comparison
Compare UUU & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UUU | BRTX |
|---|---|---|
| Founded | 1969 | 1997 |
| Country | US | US |
| Employees | N/A | N/A |
| Industry | Electronic Components | Managed Health Care |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.2M | 9.3M |
| IPO Year | 2025 | 2015 |
Fundamental Metrics
Financial Performance| Metric | UUU | BRTX |
|---|---|---|
| Price | $4.35 | $0.26 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 134.2K | ★ 1.7M |
| Earning Date | 01-01-0001 | 02-22-2026 |
| Dividend Yield | ★ 23.47% | N/A |
| EPS Growth | ★ 229.41 | 66.08 |
| EPS | ★ 0.33 | N/A |
| Revenue | ★ $23,563,554.00 | $81,000.00 |
| Revenue This Year | N/A | $24.64 |
| Revenue Next Year | N/A | $287.76 |
| P/E Ratio | $8.64 | ★ N/A |
| Revenue Growth | ★ 18.39 | N/A |
| 52 Week Low | $1.65 | $0.22 |
| 52 Week High | $8.27 | $2.28 |
Technical Indicators
Market Signals| Indicator | UUU | BRTX |
|---|---|---|
| Relative Strength Index (RSI) | 42.94 | 13.17 |
| Support Level | $4.17 | $0.22 |
| Resistance Level | $4.80 | $1.13 |
| Average True Range (ATR) | 0.43 | 0.09 |
| MACD | -0.05 | -0.09 |
| Stochastic Oscillator | 5.67 | 4.93 |
Price Performance
Historical ComparisonAbout UUU Universal Security Instruments Inc.
Universal Safety Products Inc is a U.S.-based importer and distributor of home safety devices such as ventilation fans and ground fault circuit interrupters.
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.